Last update 08 May 2025

AXR-270

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
GR
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists)
Therapeutic Areas
Eye Diseases
Active Indication
Dry Eye Syndromes
Inactive Indication
BlepharitisMeibomian Gland Dysfunction
Originator Organization
AxeroVision, Inc.
Active Organization
AxeroVision, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AXR-270
NCT04469998
/ CompletedPhase 2
A Phase I/II, Randomized, Double-Masked, Vehicle-Controlled Study of the Safety, Tolerability, and Efficacy of AXR-270 Topical Eyelid Cream in Treating Posterior Blepharitis Associated With Meibomian Gland Dysfunction
100 Clinical Results associated with AXR-270
Login to view more data
100 Translational Medicine associated with AXR-270
Login to view more data
100 Patents (Medical) associated with AXR-270
Login to view more data
100 Deals associated with AXR-270
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dry Eye SyndromesPhase 3
United States
AxeroVision, Inc.
30 Jan 2022
Meibomian Gland DysfunctionDiscovery
United States
AxeroVision, Inc.
16 Jun 2020
BlepharitisDiscovery
United States
AxeroVision, Inc.
28 May 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04469998 (CTgov)
Phase 2
Meibomian Gland Dysfunction
129
(AXR-270 Low Dose)
sgharlrhwm(whdlcffewi) = vkdkhmjjud aaqsngaikq (rpbunhdnhz, cacgqdazhg - nhrabbyiln)
View more
-
21 Jul 2023
(AXR-270 High Dose)
sgharlrhwm(whdlcffewi) = jfjljxzifh aaqsngaikq (rpbunhdnhz, kmmawzomyw - xxrvxllqlw)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free